Nucleoporins and nucleocytoplasmic transport in hematologic malignancies

被引:42
|
作者
Takeda, Akiko [1 ]
Yaseen, Nabeel R. [1 ]
机构
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
Nucleoporin; NUP98; NUP214; CRM1; XPO1; Leukemia; Acute myeloid leukemia; Acute lymphoblastic leukemia; Nuclear export; Nucleocytoplasmic transport; ACUTE MYELOID-LEUKEMIA; NUCLEAR-PORE COMPLEX; ACUTE LYMPHOBLASTIC-LEUKEMIA; MESSENGER-RNA EXPORT; ACUTE UNDIFFERENTIATED LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; ACUTE MEGAKARYOBLASTIC LEUKEMIA; GENE-EXPRESSION PATTERN; NUP214-ABL1 FUSION GENE;
D O I
10.1016/j.semcancer.2014.02.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hematologic malignancies are often associated with chromosomal rearrangements that lead to the expression of chimeric fusion proteins. Rearrangements of the genes encoding two nucleoporins, NUP98 and NUP214, have been implicated in the pathogenesis of several types of hematologic malignancies, particularly acute myeloid leukemia. NUP98 rearrangements result in fusion of an N-terminal portion of NUP98 to one of numerous proteins. These rearrangements often follow treatment with topoisomerase II inhibitors and tend to occur in younger patients. They have been shown to induce leukemia in mice and to enhance proliferation and disrupt differentiation in primary human hematopoietic precursors. NUP214 has only a few fusion partners. DEK-NUP214 is the most common NUP214 fusion in AML; it tends to occur in younger patients and is usually associated with FLT3 internal tandem duplications. The leukemogenic activity of NUP214 fusions is less well characterized. Normal nucleoporins, including NUP98 and NUP214, have important functions in nucleocytoplasmic transport, transcription, and mitosis. These functions and their disruptions by oncogenic nucleoporin fusions are discussed. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 50 条
  • [31] Chromothripsis in hematologic malignancies
    Lagunas-Rangel, Francisco Alejandro
    EXPERIMENTAL HEMATOLOGY, 2024, 132
  • [32] Angiogenesis in hematologic malignancies
    Mesters, RM
    ANNALS OF HEMATOLOGY, 2002, 81 : S72 - S74
  • [33] Angiogenesis in hematologic malignancies
    Moehler, TM
    Neben, K
    Ho, AD
    Goldschmidt, H
    ANNALS OF HEMATOLOGY, 2001, 80 (12) : 695 - 705
  • [34] Hematologic malignancies of the pancreas
    Kumar Sandrasegaran
    Anderanik Tomasian
    Khaled M. Elsayes
    Harris Nageswaran
    Akram Shaaban
    Alampady Shanbhogue
    Christine O. Menias
    Abdominal Imaging, 2015, 40 : 411 - 423
  • [35] The Microbiota in Hematologic Malignancies
    Song, Yajing
    Himmel, Bryan
    Ohrmalm, Lars
    Gyarmati, Peter
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (01)
  • [36] Hereditary Hematologic Malignancies
    DiNardo, Courtney
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S27 - S29
  • [37] Neoantigens in Hematologic Malignancies
    Biernacki, Melinda A.
    Bleakley, Marie
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [38] Gemcitabine in hematologic malignancies
    Nabhan, C
    Krett, N
    Gandhi, V
    Rosen, S
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (06) : 514 - 521
  • [39] Anemia and hematologic malignancies
    Cahn, Jean-Yves
    HEMATOLOGIE, 2006, 12 : 2 - 2
  • [40] Angiogenesis in hematologic malignancies
    T. Moehler
    K. Neben
    A. Ho
    H. Goldschmidt
    Annals of Hematology, 2001, 80 : 695 - 705